ESC2025 Premium Access

A multicenter analysis of atrial fibrillation burden reduction with antiarrhythmic drugs in patients with cardiac implantable electronic devices

Congress Presentation

About the speaker

Doctor Sarah Schwartz

Columbia University Irving Medical Centre, New York (United States of America)
0 follower

6 more presentations in this session

Use of class ic antiarrhythmic drugs in atrial fibrillation with structural heart disease: a nationwide cohort study

Speaker: Assistant Professor J. Jeong (Seoul, KR)

Thumbnail

Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomised controlled trials

Speaker: Doctor M. Casuso Alvarez (Bologna, IT)

Thumbnail

Improving management of patients with atrial fibrillation in the emergency department based on an aggressive rhythm control strategy. The HEROMEDICUS study.

Speaker: Doctor N. Argyriou (Athens, GR)

Thumbnail

Impact of statin and ezetimibe for the prevention of stroke in patients with atrial fibrillation

Speaker: Associate Professor K. Lee (Gwangju, KR)

Thumbnail

The contemporary guideline-directed medical therapy (GDMT) for heart failure is associated with a reduced incidence of new-onset atrial fibrillation in the elderly patients

Speaker: Doctor Y. Mukai (Fukuoka, JP)

Thumbnail

Access the full session

Antiarrhythmic and upstream pharmacological therapy in atrial fibrillation

Speakers: Doctor S. Schwartz, Assistant Professor J. Jeong, Doctor M. Casuso Alvarez, Doctor N. Argyriou, Associate Professor K. Lee...
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations